全球血液製品市场规模、份额、趋势和成长分析报告（2026-2034年）

预计血液製品市场将从 2025 年的 385 亿美元成长到 2034 年的 799.7 亿美元，2026 年至 2034 年的复合年增长率为 8.46%。

受输血需求不断增长以及需要使用血液製品的慢性疾病患病率上升的推动，血液製品市场正经历强劲增长。随着全球医疗系统致力于改善患者预后，安全有效的血液製品的重要性不言而喻。这个市场涵盖多种产品，包括全血、红血球、血浆和血小板，所有这些产品在医疗和外科手术中都发挥着至关重要的作用。人口老化和创伤病例的急剧增加进一步推动了对血液製品的需求，凸显了高效血液收集、处理和配送系统的必要性。

技术进步正显着提升血液製品市场的竞争力，血液处理和储存技术的创新提高了产品的安全性和有效性。自动化采血系统和先进检测方法的进步提高了营运效率，降低了污染风险。此外，数据分析和人工智慧技术在血液管理系统中的应用优化了库存管理，确保血液製品在最需要的时间和地点都能及时供应。随着市场的不断发展，那些优先投资于最尖端科技和品质保证的企业有望获得竞争优势。

此外，血液製品市场日益受到旨在确保血液供应安全的法规结构和公共卫生措施的影响。各国政府和卫生组织已实施严格的法规，以促进血液安全并鼓励自愿捐血宣传活动。这种对安全性和可近性的重视正在推动对捐血基础设施和宣传项目的投资，从而为市场成长创造机会。随着对血液製品需求的持续成长，那些遵守监管标准并与当地社区积极互动的公司将在这个重要领域占据有利地位，取得成功。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球血液製品市场（按类型划分）

• 市场分析、洞察与预测
• 白蛋白
• 免疫球蛋白
• 凝血因子
• 其他的

5. 全球血液製品市场依应用领域划分

• 市场分析、洞察与预测
• 出血伤口
• 免疫力缺乏
• HBV
• 破伤风
• 狂犬病
• 血友病
• 其他的

6. 全球血液製品市场（依地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • CSL
  • BPL
  • Mitsubishi Tanabe Pharma Corporation
  • Takeda
  • Octapharma AG
  • Baxter
  • Grifols
  • Kedrion SpA
  • Hualan Bio

The Blood Products Market size is expected to reach USD 79.97 Billion in 2034 from USD 38.50 Billion (2025) growing at a CAGR of 8.46% during 2026-2034.

The Blood Products market is experiencing robust growth, driven by the increasing demand for blood transfusions and the rising prevalence of chronic diseases that necessitate blood product utilization. As healthcare systems worldwide strive to improve patient outcomes, the importance of safe and effective blood products cannot be overstated. This market encompasses a wide range of products, including whole blood, red blood cells, plasma, and platelets, all of which play critical roles in medical treatments and surgical procedures. The growing aging population and the surge in trauma cases are further propelling the demand for blood products, highlighting the need for efficient blood collection, processing, and distribution systems.

Technological advancements are significantly enhancing the capabilities of the Blood Products market, with innovations in blood processing and storage techniques improving product safety and efficacy. The development of automated blood collection systems and advanced testing methods is streamlining operations and reducing the risk of contamination. Additionally, the integration of data analytics and artificial intelligence in blood management systems is optimizing inventory control and ensuring that blood products are available when and where they are needed most. As the market continues to evolve, companies that invest in cutting-edge technologies and prioritize quality assurance will likely gain a competitive advantage.

Moreover, the Blood Products market is increasingly influenced by regulatory frameworks and public health initiatives aimed at ensuring the safety and availability of blood supplies. Governments and health organizations are implementing stringent regulations to enhance blood safety and promote voluntary blood donation campaigns. This focus on safety and accessibility is driving investment in blood donation infrastructure and awareness programs, creating opportunities for growth in the market. As the demand for blood products continues to rise, companies that align their operations with regulatory standards and engage in community outreach will be well-positioned to succeed in this vital sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Albumin
• Immunoglobulin
• Clotting Factor
• Others

By Application

• Bleeding Wound
• Immunodeficiency
• HBV
• Tetanus
• Rabies
• Hemophilia
• Others

COMPANIES PROFILED

• CSL, BPL, Mitsubishi Tanabe Pharma Corporation, Takeda, Octapharma AG, Baxter, Grifols, Kedrion SpA, Hualan Bio

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BLOOD PRODUCTS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Albumin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunoglobulin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Clotting Factor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BLOOD PRODUCTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Bleeding Wound Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Immunodeficiency Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. HBV Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Tetanus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Rabies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Hemophilia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BLOOD PRODUCTS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL BLOOD PRODUCTS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 CSL
  • 8.2.2 BPL
  • 8.2.3 Mitsubishi Tanabe Pharma Corporation
  • 8.2.4 Takeda
  • 8.2.5 Octapharma AG
  • 8.2.6 Baxter
  • 8.2.7 Grifols
  • 8.2.8 Kedrion SpA
  • 8.2.9 Hualan Bio